140 related articles for article (PubMed ID: 17718951)
61. Alpha,beta-poly(L-aspartate-graft-PEI): A pseudo-branched PEI as a gene carrier with low toxicity and high transfection efficiency.
Yu JH; Quan JS; Huang J; Wang CY; Sun B; Nah JW; Cho MH; Cho CS
Acta Biomater; 2009 Sep; 5(7):2485-94. PubMed ID: 19357003
[TBL] [Abstract][Full Text] [Related]
62. A dendritic tetra(bisphosphonic acid) for improved targeting of proteins to bone.
Bansal G; Wright JE; Kucharski C; Uludağ H
Angew Chem Int Ed Engl; 2005 Jun; 44(24):3710-4. PubMed ID: 15880536
[No Abstract] [Full Text] [Related]
63. Poly(propylene imine) dendrimers with histidine-maltose shell as novel type of nanoparticles for synapse and memory protection.
Aso E; Martinsson I; Appelhans D; Effenberg C; Benseny-Cases N; Cladera J; Gouras G; Ferrer I; Klementieva O
Nanomedicine; 2019 Apr; 17():198-209. PubMed ID: 30708052
[TBL] [Abstract][Full Text] [Related]
64. Matrix modifications modulate ophthalmic drug delivery from photo-cross-linked poly(propylene fumarate)-based networks.
Haesslein A; Hacker MC; Ueda H; Ammon DM; Borazjani RN; Kunzler JF; Salamone JC; Mikos AG
J Biomater Sci Polym Ed; 2009; 20(1):49-69. PubMed ID: 19105900
[TBL] [Abstract][Full Text] [Related]
65. High gene delivery in tumor by intratumoral injection of tetraarginine-PEG lipid-coated protamine/DNA.
Fujita T; Furuhata M; Hattori Y; Kawakami H; Toma K; Maitani Y
J Control Release; 2008 Jul; 129(2):124-7. PubMed ID: 18513820
[TBL] [Abstract][Full Text] [Related]
66. [Lysine dendrimers as vectors for delivering genetic constructs to eukaryotic cells].
Kiselev AV; Il'ina PL; Egorova AA; Baranov AN; Gur'ianov IA; Baianova NV; Tarasenko II; Lesina EA; Vlasov GP; Baranov VS
Genetika; 2007 Jun; 43(6):725-33. PubMed ID: 17853798
[TBL] [Abstract][Full Text] [Related]
67. Star-shaped cationic polymers by atom transfer radical polymerization from beta-cyclodextrin cores for nonviral gene delivery.
Xu FJ; Zhang ZX; Ping Y; Li J; Kang ET; Neoh KG
Biomacromolecules; 2009 Feb; 10(2):285-93. PubMed ID: 19128039
[TBL] [Abstract][Full Text] [Related]
68. DNA-based therapeutics and DNA delivery systems: a comprehensive review.
Patil SD; Rhodes DG; Burgess DJ
AAPS J; 2005 Apr; 7(1):E61-77. PubMed ID: 16146351
[TBL] [Abstract][Full Text] [Related]
69. Remarkable drug-release enhancement with an elimination-based AB3 self-immolative dendritic amplifier.
Sagi A; Segal E; Satchi-Fainaro R; Shabat D
Bioorg Med Chem; 2007 Jun; 15(11):3720-7. PubMed ID: 17416532
[TBL] [Abstract][Full Text] [Related]
70. Evaluation of generations 2, 3 and 4 arginine modified PAMAM dendrimers for gene delivery.
Nam HY; Hahn HJ; Nam K; Choi WH; Jeong Y; Kim DE; Park JS
Int J Pharm; 2008 Nov; 363(1-2):199-205. PubMed ID: 18718514
[TBL] [Abstract][Full Text] [Related]
71. Degradable PEG-folate coated poly(DMAEA-co-BA)phosphazene-based polyplexes exhibit receptor-specific gene expression.
Luten J; van Steenbergen MJ; Lok MC; de Graaff AM; van Nostrum CF; Talsma H; Hennink WE
Eur J Pharm Sci; 2008 Mar; 33(3):241-51. PubMed ID: 18207707
[TBL] [Abstract][Full Text] [Related]
72. Water-soluble carbosilane dendrimers protect phosphorothioate oligonucleotides from binding to serum proteins.
Chonco L; Bermejo-Martín JF; Ortega P; Shcharbin D; Pedziwiatr E; Klajnert B; de la Mata FJ; Eritja R; Gómez R; Bryszewska M; Muñoz-Fernandez MA
Org Biomol Chem; 2007 Jun; 5(12):1886-93. PubMed ID: 17551637
[TBL] [Abstract][Full Text] [Related]
73. Receptor-mediated gene delivery by folate-PEG-baculovirus in vitro.
Kim YK; Choi JY; Yoo MK; Jiang HL; Arote R; Je YH; Cho MH; Cho CS
J Biotechnol; 2007 Sep; 131(3):353-61. PubMed ID: 17727999
[TBL] [Abstract][Full Text] [Related]
74. Dendrimers as versatile platform in drug delivery applications.
Svenson S
Eur J Pharm Biopharm; 2009 Mar; 71(3):445-62. PubMed ID: 18976707
[TBL] [Abstract][Full Text] [Related]
75. Targeting cancer cells with biotin-dendrimer conjugates.
Yang W; Cheng Y; Xu T; Wang X; Wen LP
Eur J Med Chem; 2009 Feb; 44(2):862-8. PubMed ID: 18550227
[TBL] [Abstract][Full Text] [Related]
76. Biocompatible chitosan-DNAzyme nanoparticle exhibits enhanced biological activity.
Dass CR; Friedhuber AM; Khachigian LM; Dunstan DE; Choong PF
J Microencapsul; 2008 Sep; 25(6):421-5. PubMed ID: 18465314
[TBL] [Abstract][Full Text] [Related]
77. Cytotoxicity of polypropylenimine dendrimer conjugates on cultured endothelial cells.
Stasko NA; Johnson CB; Schoenfisch MH; Johnson TA; Holmuhamedov EL
Biomacromolecules; 2007 Dec; 8(12):3853-9. PubMed ID: 18004811
[TBL] [Abstract][Full Text] [Related]
78. Nucleic acid therapeutic carriers with on-demand triggered release.
Venkatesh S; Wower J; Byrne ME
Bioconjug Chem; 2009 Sep; 20(9):1773-82. PubMed ID: 19670897
[TBL] [Abstract][Full Text] [Related]
79. Characterization of carbosilane dendrimers as effective carriers of siRNA to HIV-infected lymphocytes.
Weber N; Ortega P; Clemente MI; Shcharbin D; Bryszewska M; de la Mata FJ; Gómez R; Muñoz-Fernández MA
J Control Release; 2008 Nov; 132(1):55-64. PubMed ID: 18727943
[TBL] [Abstract][Full Text] [Related]
80. Antagomirzymes: oligonucleotide enzymes that specifically silence microRNA function.
Jadhav VM; Scaria V; Maiti S
Angew Chem Int Ed Engl; 2009; 48(14):2557-60. PubMed ID: 19229913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
